Entrada Therapeutics Email Formats
Biotechnology Research • 
Boston, Massachusetts, United States • 101-200 Employees
Entrada Therapeutics Email Formats
Entrada Therapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@entradatx.com), used 92% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@entradatx.com | 92% |
{first initial}{last name} | jdoe@entradatx.com | 8% |
Key Contacts at Entrada Therapeutics
Gina Simmons Chapman
Independent Board Director
Mah Kheirabadi
Director Of Discovery Chemistry
Xiulong Shen
Associate Director - Discovery Biology
Gina Guglielmi
Director, Head Of Talent Acquisition
Amy Hicks
Director
Kevin Nickl
Associate Director Clinical Data Management
Divya Reddy
Medical Director, Clinical Development
Samantha Soloway
Director, Program Management
Paul Buckley
Associate Director, Quality
Julia Kaminski
Director, Hr Business Partner
Company overview
| Headquarters | Boston, Massachusetts, United States |
| Phone number | +18575209158 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Founded | 2016 |
| Employees | 101-200 |
| Socials |
About Entrada Therapeutics
Headquartered in Boston’s Seaport community, Entrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Our Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, we are advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. For more information about Entrada, please visit our website, www.entradatx.com
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Entrada Therapeutics has 95 employees across 13 departments.
Departments
Number of employees
Funding Data
Explore Entrada Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Entrada Therapeutics Tech Stack
Discover the technologies and tools that power Entrada Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Web frameworks
JavaScript libraries
Maps
CDN
Miscellaneous
Security
Programming languages
JavaScript frameworks
Analytics
Video players
CMS
SEO
Australia
United Kingdom
Frequently asked questions
4.8
40,000 users
